RE: Oxilio make an acquisition...30 Mar 2022 21:38
Interesting reading. LSHS was incorporated in October 2020, shortly after DG left Nuformix.
Looks like Oxilio initiated the licensing discussions for NXP001 through DG. DG also hooked up Oxilio with Trx Biosciences, according to the pdf on the website.
The acquisition is a share-based transaction, so I presume DG now has shares in Oxilio too.
That's one way to get around the £2m market cap on royalties, I suppose.